Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00450177 · ClinicalTrials.gov registry record · Phase 2
Efficacy of Enteral Iron Supplementation in Critical Illness
A Phase 2 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT00450177 is a Phase 2 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 200 participants.
The verdict
NCT00450177, a Phase 2 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the efficacy of enteral iron supplementation for improving anemia, decreasing the risk of blood transfusion, and decreasing mortality in patients who are hospitalized in the intensive care unit. This study will also address any relationship between enteral iron supplementation and risk of infection.
Interventions
- DRUG Ferrous Sulfate
- DRUG Placebo Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00450177
The ClinicalTrials.gov registry entry for NCT00450177 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ferrous Sulfate is the first listed.
NCT00450177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00450177 about?
NCT00450177 is a clinical study titled "Efficacy of Enteral Iron Supplementation in Critical Illness". The purpose of this study is to investigate the efficacy of enteral iron supplementation for improving anemia, decreasing the risk of blood transfusion, and decreasing mortality in patients who are hospitalized in the intensive care unit. This study will also address any relationship between enteral...
What is the current status of trial NCT00450177?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2006-01. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00450177?
The interventions under investigation include: Ferrous Sulfate (DRUG), Placebo Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT00450177?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.